BioLife Solutions, Inc.BLFSNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -119.69% | +29.88% | +28.94% | -8.19% | +0.00% |
| Gross Profit Growth | -8.71% | +28.96% | +24.43% | -21.02% | +53.27% |
| EBITDA Growth | +0.00% | +0.00% | -1457.01% | +46.07% | -27.40% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +319.91% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | -71.63% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | -71.67% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | -70.46% |
| Weighted Average Shares Growth | +4.07% | +3.75% | +3.90% | +3.79% | +2.37% |
| Weighted Average Shares Diluted Growth | +7.16% | +3.75% | +3.90% | +5.52% | +1.27% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -28.82% | +0.00% | +14.07% | +27.11% | +198.84% |
| Free Cash Flow Growth | -56.17% | +0.00% | +2.95% | -24.02% | +384.22% |
| Receivables Growth | -50.86% | -50.65% | -44.31% | -39.49% | -13.25% |
| Inventory Growth | -33.24% | -36.50% | -14.79% | -13.53% | +3.94% |
| Asset Growth | -3.20% | -1.61% | +3.27% | +2.73% | +1.60% |
| Book Value per Share Growth | -0.71% | +1.94% | +3.95% | +4.72% | +4.12% |
| Debt Growth | -10.80% | -34.21% | -33.77% | -47.34% | -40.69% |
| R&D Expense Growth | -75.34% | -37.63% | +14.15% | +32.15% | -93.92% |
| SG&A Expenses Growth | -66.89% | +10.37% | +19.72% | -1.96% | +116.35% |